Matthew Bennett Arnold
Net Worth
Last updated:
What is Matthew Bennett Arnold net worth?
The estimated net worth of Mr. Matthew Bennett Arnold is at least $20,084,119 as of 14 Jan 2019. He owns shares worth $19,829,119 as insider and has received compensation worth at least $255,000 in Solid Biosciences Inc..
What is the salary of Matthew Bennett Arnold?
Mr. Matthew Bennett Arnold salary is $42,500 per year as Co-Founder & Board Member in Solid Biosciences Inc..
How old is Matthew Bennett Arnold?
Mr. Matthew Bennett Arnold is 55 years old, born in 1970.
What stocks does Matthew Bennett Arnold currently own?
As insider, Mr. Matthew Bennett Arnold owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | Co-Founder & Board Member | 3,389,593 | $5.85 | $19,829,119 |
What does Solid Biosciences Inc. do?
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Matthew Bennett Arnold insider trading
Solid Biosciences Inc.
Mr. Matthew Bennett Arnold has made 2 insider trades in 2019, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of SLDB stock on 14 Jan 2019.
The largest trade he's ever made was exercising 5,000 units of SLDB stock on 7 Jan 2019. As of 14 Jan 2019 he still owns at least 3,389,593 units of SLDB stock.
Solid Biosciences key executives
Solid Biosciences Inc. executives and other stock owners filed with the SEC:
- Dr. Carl Ashley Morris (55) Chief Scientific Officer
- Mr. Ilan Ganot (51) Co-founder, Pres, Chief Executive Officer & Director
- Mr. Matthew Bennett Arnold (55) Co-Founder & Board Member